JB/CALL/FRESENIUS/28/0.125/20.09.24 Share Price

Warrant

FREWJB

CH1249396511

Market Closed - Swiss Exchange 08:50:00 11/06/2024 pm IST
0.35 CHF -12.50% Intraday chart for JB/CALL/FRESENIUS/28/0.125/20.09.24
Current month+9.38%
1 month+16.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
11/24/11 0.35 -12.50%
10/24/10 0.4 -6.98%
06/24/06 0.43 +16.22%
05/24/05 0.37 +12.12%
04/24/04 0.33 +3.13%

Delayed Quote Swiss Exchange

Last update June 11, 2024 at 08:50 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
Issuer Bank Julius Bär
FREWJB
ISINCH1249396511
Date issued 21/03/2023
Strike 28
Maturity 20/09/2024 (101 Days)
Parity 8 : 1
Emission price 0.29 CHF
Emission volume N/A
Settlement les deux
Currency CHF

Technical Indicators

Highest since issue 0.66 CHF
Lowest since issue 0.11 CHF
Delta0.67x
Omega 6.926
Premium4.86x
Gearing10.29x
Moneyness 1.051
Difference Strike -1.43
Difference Strike %-5.11%
Spread 0.01 CHF
Spread %2.86%
Theoretical value 0.3450
Implied Volatility 31.29 %
Total Loss Probability 38.79 %
Intrinsic value 0.1724
Present value 0.1726
Break even 30.86 CHF
Theta-0.01x
Vega0.01x
Rho0.01x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
30.16 EUR
Average target price
37.26 EUR
Spread / Average Target
+23.53%
Consensus
  1. Stock Market
  2. Warrants
  3. FREWJB Warrant